跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 637 条关于
“29F.1A12”
全部
637
临床试验
226
药物
350
机构
2
资讯
59
去年
Researchers Identify Anti-Mouse PD-1 Agonist Antibodies That Inhibit T Cell Activation
去年
NLX-112 Receives Orphan Drug Designation in Europe for Spinocerebellar Ataxia
9个月前
PT-112 Demonstrates Promising Efficacy in Recurrent Thymoma Phase 2 Trial
去年
TME Pharma's NOX-A12 Shows Significant Survival Benefit in Glioblastoma Trial
4年前
BO-112 Plus Pembrolizumab Shows Promise in PD-1 Resistant Advanced Melanoma
8个月前
JJP Biologics Reports Positive Phase I Results for First-in-Class Anti-CD89 Antibody JJP-1212
去年
TME Pharma Implements Strategic Restructuring to Advance NOX-A12 and NOX-E36 Development
7个月前
Shilpa Medicare Files First US Transdermal Patch ANDA for Rotigotine, Targeting $112 Million Market
去年
FDA Greenlights Promontory Therapeutics' Phase 3 Trial Design for PT-112 in Metastatic Prostate Cancer
2年前
Promontory Therapeutics Completes Enrollment in Phase 2 Trial of PT-112 for Late-Stage Metastatic Prostate Cancer
第 1 页,共 6 页
上一页
下一页